Miguel Angel Fernandez-Moreno
Overview
Explore the profile of Miguel Angel Fernandez-Moreno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
310
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Antolinez-Fernandez A, Esteban-Ramos P, Fernandez-Moreno M, Clemente P
Front Cell Dev Biol
. 2024 Jun;
12:1410245.
PMID: 38855161
Mitochondria play a central role in cellular metabolism producing the necessary ATP through oxidative phosphorylation. As a remnant of their prokaryotic past, mitochondria contain their own genome, which encodes 13...
2.
Alcala S, Villarino L, Ruiz-Canas L, Couceiro J, Martinez-Calvo M, Palencia-Campos A, et al.
J Exp Clin Cancer Res
. 2024 Jan;
43(1):33.
PMID: 38281027
Background: Previous studies by our group have shown that oxidative phosphorylation (OXPHOS) is the main pathway by which pancreatic cancer stem cells (CSCs) meet their energetic requirements; therefore, OXPHOS represents...
3.
Gonzalez C, Martinez-Sanchez L, Clemente P, Toivonen J, Arredondo J, Fernandez-Moreno M, et al.
FEBS Open Bio
. 2023 Nov;
14(2):276-289.
PMID: 38013241
Mitochondrial carrier homologs 1 (MTCH1) and 2 (MTCH2) are orphan members of the mitochondrial transporter family SLC25. Human MTCH1 is also known as presenilin 1-associated protein, PSAP. MTCH2 is a...
4.
Bujan N, Moren C, Garcia-Garcia F, Blazquez A, Carnicer C, Cortes A, et al.
Antioxidants (Basel)
. 2022 Apr;
11(4).
PMID: 35453428
The quantification of mitochondrial respiratory chain (MRC) enzymatic activities is essential for diagnosis of a wide range of mitochondrial diseases, ranging from inherited defects to secondary dysfunctions. MRC lesion is...
5.
Pescador N, Francisco V, Vazquez P, Esquinas E, Gonzalez-Paramos C, Valdecantos M, et al.
Redox Biol
. 2021 Nov;
48:102171.
PMID: 34736121
Therapeutic potential of metformin in obese/diabetic patients has been associated to its ability to combat insulin resistance. However, it remains largely unknown the signaling pathways involved and whether some cell...
6.
Valle S, Alcala S, Martin-Hijano L, Cabezas-Sainz P, Navarro D, Munoz E, et al.
Nat Commun
. 2020 Oct;
11(1):5265.
PMID: 33067432
Pancreatic ductal adenocarcinoma (PDAC), the fourth leading cause of cancer death, has a 5-year survival rate of approximately 7-9%. The ineffectiveness of anti-PDAC therapies is believed to be due to...
7.
Mayoral-Varo V, Calcabrini A, Sanchez-Bailon M, Martinez-Costa O, Gonzalez-Paramos C, Ciordia S, et al.
PLoS One
. 2020 Jul;
15(7):e0235850.
PMID: 32673341
Deregulation of Src kinases is associated with cancer. We previously showed that SrcDN conditional expression in MCF7 cells reduces tumorigenesis and causes tumor regression in mice. However, it remained unclear...
8.
Alcala S, Sancho P, Martinelli P, Navarro D, Pedrero C, Martin-Hijano L, et al.
Nat Commun
. 2020 May;
11(1):2682.
PMID: 32472071
Pancreatic cancer stem cells (PaCSCs) drive pancreatic cancer tumorigenesis, chemoresistance and metastasis. While eliminating this subpopulation of cells would theoretically result in tumor eradication, PaCSCs are extremely plastic and can...
9.
Tiana M, Acosta-Iborra B, Hernandez R, Galiana C, Fernandez-Moreno M, Jimenez B, et al.
RNA
. 2020 Apr;
26(8):1006-1022.
PMID: 32295863
Cells adapt to environmental changes, including fluctuations in oxygen levels, through the induction of specific gene expression programs. However, most transcriptomic studies do not distinguish the relative contribution of transcription,...
10.
Cruz-Bermudez A, Vallejo C, Vicente-Blanco R, Gallardo M, Fernandez-Moreno M, Quintanilla M, et al.
Oncotarget
. 2020 Mar;
11(11):1006.
PMID: 32215189
[This corrects the article DOI: 10.18632/oncotarget.3698.].